Cargando…

Biopharmaceuticals from microorganisms: from production to purification

The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons...

Descripción completa

Detalles Bibliográficos
Autores principales: Jozala, Angela Faustino, Geraldes, Danilo Costa, Tundisi, Louise Lacalendola, Feitosa, Valker de Araújo, Breyer, Carlos Alexandre, Cardoso, Samuel Leite, Mazzola, Priscila Gava, Oliveira-Nascimento, Laura de, Rangel-Yagui, Carlota de Oliveira, Magalhães, Pérola de Oliveira, Oliveira, Marcos Antonio de, Pessoa, Adalberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156500/
https://www.ncbi.nlm.nih.gov/pubmed/27838289
http://dx.doi.org/10.1016/j.bjm.2016.10.007
_version_ 1782481273612140544
author Jozala, Angela Faustino
Geraldes, Danilo Costa
Tundisi, Louise Lacalendola
Feitosa, Valker de Araújo
Breyer, Carlos Alexandre
Cardoso, Samuel Leite
Mazzola, Priscila Gava
Oliveira-Nascimento, Laura de
Rangel-Yagui, Carlota de Oliveira
Magalhães, Pérola de Oliveira
Oliveira, Marcos Antonio de
Pessoa, Adalberto
author_facet Jozala, Angela Faustino
Geraldes, Danilo Costa
Tundisi, Louise Lacalendola
Feitosa, Valker de Araújo
Breyer, Carlos Alexandre
Cardoso, Samuel Leite
Mazzola, Priscila Gava
Oliveira-Nascimento, Laura de
Rangel-Yagui, Carlota de Oliveira
Magalhães, Pérola de Oliveira
Oliveira, Marcos Antonio de
Pessoa, Adalberto
author_sort Jozala, Angela Faustino
collection PubMed
description The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques. In this review, we discuss the technology involved in the bioprocess and describe the available strategies and main advances in microbial fermentation and purification process to obtain biopharmaceuticals.
format Online
Article
Text
id pubmed-5156500
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-51565002016-12-19 Biopharmaceuticals from microorganisms: from production to purification Jozala, Angela Faustino Geraldes, Danilo Costa Tundisi, Louise Lacalendola Feitosa, Valker de Araújo Breyer, Carlos Alexandre Cardoso, Samuel Leite Mazzola, Priscila Gava Oliveira-Nascimento, Laura de Rangel-Yagui, Carlota de Oliveira Magalhães, Pérola de Oliveira Oliveira, Marcos Antonio de Pessoa, Adalberto Braz J Microbiol Review The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques. In this review, we discuss the technology involved in the bioprocess and describe the available strategies and main advances in microbial fermentation and purification process to obtain biopharmaceuticals. Elsevier 2016-10-26 /pmc/articles/PMC5156500/ /pubmed/27838289 http://dx.doi.org/10.1016/j.bjm.2016.10.007 Text en © 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Jozala, Angela Faustino
Geraldes, Danilo Costa
Tundisi, Louise Lacalendola
Feitosa, Valker de Araújo
Breyer, Carlos Alexandre
Cardoso, Samuel Leite
Mazzola, Priscila Gava
Oliveira-Nascimento, Laura de
Rangel-Yagui, Carlota de Oliveira
Magalhães, Pérola de Oliveira
Oliveira, Marcos Antonio de
Pessoa, Adalberto
Biopharmaceuticals from microorganisms: from production to purification
title Biopharmaceuticals from microorganisms: from production to purification
title_full Biopharmaceuticals from microorganisms: from production to purification
title_fullStr Biopharmaceuticals from microorganisms: from production to purification
title_full_unstemmed Biopharmaceuticals from microorganisms: from production to purification
title_short Biopharmaceuticals from microorganisms: from production to purification
title_sort biopharmaceuticals from microorganisms: from production to purification
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156500/
https://www.ncbi.nlm.nih.gov/pubmed/27838289
http://dx.doi.org/10.1016/j.bjm.2016.10.007
work_keys_str_mv AT jozalaangelafaustino biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT geraldesdanilocosta biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT tundisilouiselacalendola biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT feitosavalkerdearaujo biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT breyercarlosalexandre biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT cardososamuelleite biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT mazzolapriscilagava biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT oliveiranascimentolaurade biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT rangelyaguicarlotadeoliveira biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT magalhaesperoladeoliveira biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT oliveiramarcosantoniode biopharmaceuticalsfrommicroorganismsfromproductiontopurification
AT pessoaadalberto biopharmaceuticalsfrommicroorganismsfromproductiontopurification